Yep, read though a few reports and can also see after market GILD is up over 16%. This is not a speccy biotech. It is a USD$100B company. They cured hepatitis. So the market is telling me they have a valid cure. That will be a game changer in terms of risk management for opening up society and the economy again.
They report the initial results this month. That will probably confirm the bottom of the economic damaging policies, imo. Markets will probably not wait for the results.
Chart Update, page-11226
-
- There are more pages in this discussion • 14,175 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.90 |
Change
-0.090(1.50%) |
Mkt cap ! $4.271B | |||
| Open | High | Low | Value | Volume |
| $5.96 | $5.97 | $5.86 | $19.03M | 3.213M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4800 | $5.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.91 | 29913 | 3 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| A2M (ASX) Chart |